We are live on
!
Find out more
AC
Athos Capital Portfolio holdings
AUM
$324M
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
-1.7%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$63.4M
(+24%)
Cap. Flow
+$74M
Cap. Flow
% of AUM
22.83%
Top 10 Holdings %
Top 10 Hldgs %
74.87%
Holding
50
New
13
Increased
12
Reduced
3
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$48.8M |
| 2 |
Vipshop
VIPS
|
+$25.1M |
| 3 |
JHG
Janus Henderson
JHG
|
+$11.2M |
| 4 |
Webster Financial
WBS
|
+$10.3M |
| 5 |
Electronic Arts
EA
|
+$8.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$30.5M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$13.3M |
| 3 |
CDTX
Cidara Therapeutics
CDTX
|
+$8.84M |
| 4 |
CFLT
Confluent
CFLT
|
+$3.45M |
| 5 |
KE Holdings
BEKE
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 35.06% |
| 2 | Healthcare | 12.67% |
| 3 | Financials | 10.55% |
| 4 | Real Estate | 10.38% |
| 5 | Consumer Discretionary | 10.04% |
Similar funds
GREM
OAP
2L
THCM
WG
ITIM
QPW
FAL
Athos Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Athos Capital held 50 positions worth $324M, up 24% from $261M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Athos Capital deployed $74M of net new capital in Q1 2026, opening 13 new positions and adding to 12 existing holdings. Its largest new stake was Warner Bros: 1,744,075 shares worth $47.9M.
By sector, the portfolio is most concentrated in Communication Services at 35% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Kenvue, an estimated $30.5M trimmed.
- Athos Capital's largest Q1 2026 buy was Warner Bros: 1,744,075 shares worth $47.9M.
- Athos Capital added most to Janus Henderson in Q1 2026, an estimated $11.2M increase.
- Athos Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $30.5M.
- Athos Capital fully exited Avidity Biosciences in Q1 2026, selling an estimated $13.3M.
- Athos Capital's ten largest holdings make up 75% of its $324M portfolio in Q1 2026.
- Athos Capital opened 13 new positions and closed 6 in Q1 2026.
- Athos Capital's portfolio value rose 24% quarter-over-quarter to $324M.
Based on Athos Capital's 13F filing for Q1 2026, filed 13 May 2026.